167 related articles for article (PubMed ID: 14566653)
1. Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene.
Gränse L; Bergstrand I; Thiselton D; Ponjavic V; Heijl A; Votruba M; Andréasson S
Ophthalmic Genet; 2003 Dec; 24(4):233-45. PubMed ID: 14566653
[TBL] [Abstract][Full Text] [Related]
2. Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level.
Reis A; Mateus C; Viegas T; Florijn R; Bergen A; Silva E; Castelo-Branco M
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):221-34. PubMed ID: 22865259
[TBL] [Abstract][Full Text] [Related]
3. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation.
Russo A; Delcassi L; Marchina E; Semeraro F
Ophthalmic Genet; 2013; 34(1-2):69-74. PubMed ID: 22779427
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.
Heiduschka P; Schnichels S; Fuhrmann N; Hofmeister S; Schraermeyer U; Wissinger B; Alavi MV
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1424-31. PubMed ID: 19834041
[TBL] [Abstract][Full Text] [Related]
5. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations.
Miyata K; Nakamura M; Kondo M; Lin J; Ueno S; Miyake Y; Terasaki H
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):820-4. PubMed ID: 17251483
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
[TBL] [Abstract][Full Text] [Related]
7. The natural history of OPA1-related autosomal dominant optic atrophy.
Cohn AC; Toomes C; Hewitt AW; Kearns LS; Inglehearn CF; Craig JE; Mackey DA
Br J Ophthalmol; 2008 Oct; 92(10):1333-6. PubMed ID: 18653586
[TBL] [Abstract][Full Text] [Related]
8. The reduction of temporal optic nerve head microcirculation in autosomal dominant optic atrophy.
Inoue M; Himori N; Kunikata H; Takeshita T; Aizawa N; Shiga Y; Omodaka K; Nishiguchi KM; Takahashi H; Nakazawa T
Acta Ophthalmol; 2016 Nov; 94(7):e580-e585. PubMed ID: 26936288
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
10. First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation.
Kamakari S; Koutsodontis G; Tsilimbaris M; Fitsios A; Chrousos G
Mol Vis; 2014; 20():691-703. PubMed ID: 24883014
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.
Hayashi T; Sasano H; Katagiri S; Tsunoda K; Kameya S; Nakazawa M; Iwata T; Tsuneoka H
Jpn J Ophthalmol; 2017 Sep; 61(5):395-401. PubMed ID: 28668999
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation of the OPA1 gene in a Japanese family with optic atrophy type 1.
Shimizu S; Mori N; Kishi M; Sugata H; Tsuda A; Kubota N
Jpn J Ophthalmol; 2002; 46(3):336-40. PubMed ID: 12063046
[TBL] [Abstract][Full Text] [Related]
13. Specific deficits in visual electrophysiology in a mouse model of dominant optic atrophy.
Barnard AR; Charbel Issa P; Perganta G; Williams PA; Davies VJ; Sekaran S; Votruba M; MacLaren RE
Exp Eye Res; 2011 Nov; 93(5):771-7. PubMed ID: 21803037
[TBL] [Abstract][Full Text] [Related]
14. Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.
Hayashi T; Gekka T; Omoto S; Takeuchi T; Kitahara K
Ophthalmic Res; 2005; 37(4):214-24. PubMed ID: 16006781
[TBL] [Abstract][Full Text] [Related]
15. Dominant optic atrophy: correlation between clinical and molecular genetic studies.
Puomila A; Huoponen K; Mäntyjärvi M; Hämäläinen P; Paananen R; Sankila EM; Savontaus ML; Somer M; Nikoskelainen E
Acta Ophthalmol Scand; 2005 Jun; 83(3):337-46. PubMed ID: 15948788
[TBL] [Abstract][Full Text] [Related]
16. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy.
Shimizu S; Mori N; Kishi M; Sugata H; Tsuda A; Kubota N
Am J Ophthalmol; 2003 Feb; 135(2):256-7. PubMed ID: 12566046
[TBL] [Abstract][Full Text] [Related]
18. Visual field loss in optic disc drusen patients correlates with central retinal artery blood velocity patterns.
Abegão Pinto L; Vandewalle E; Marques-Neves C; Stalmans I
Acta Ophthalmol; 2014 Jun; 92(4):e286-91. PubMed ID: 24456173
[TBL] [Abstract][Full Text] [Related]
19. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
[TBL] [Abstract][Full Text] [Related]
20. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.
Sarzi E; Angebault C; Seveno M; Gueguen N; Chaix B; Bielicki G; Boddaert N; Mausset-Bonnefont AL; Cazevieille C; Rigau V; Renou JP; Wang J; Delettre C; Brabet P; Puel JL; Hamel CP; Reynier P; Lenaers G
Brain; 2012 Dec; 135(Pt 12):3599-613. PubMed ID: 23250881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
